These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19062296)

  • 1. Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis.
    Harada T; Nakagawa Y; Wadkins RM; Potter PM; Wheelock CE
    Bioorg Med Chem; 2009 Jan; 17(1):149-64. PubMed ID: 19062296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of sulfur oxidation state and steric bulk upon trifluoromethyl ketone (TFK) binding kinetics to carboxylesterases and fatty acid amide hydrolase (FAAH).
    Wheelock CE; Nishi K; Ying A; Jones PD; Colvin ME; Olmstead MM; Hammock BD
    Bioorg Med Chem; 2008 Feb; 16(4):2114-30. PubMed ID: 18023188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of mammalian carboxylesterase inhibition by trifluoromethylketone-containing compounds.
    Wadkins RM; Hyatt JL; Edwards CC; Tsurkan L; Redinbo MR; Wheelock CE; Jones PD; Hammock BD; Potter PM
    Mol Pharmacol; 2007 Mar; 71(3):713-23. PubMed ID: 17167034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of ab initio calculations to predict the biological potency of carboxylesterase inhibitors.
    Wheelock CE; Colvin ME; Uemura I; Olmstead MM; Sanborn JR; Nakagawa Y; Jones AD; Hammock BD
    J Med Chem; 2002 Dec; 45(25):5576-93. PubMed ID: 12459025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of new carboxylesterase inhibitors and evaluation of potency and water solubility.
    Wheelock CE; Severson TF; Hammock BD
    Chem Res Toxicol; 2001 Dec; 14(12):1563-72. PubMed ID: 11743738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of classical and 3-D QSAR to examine the hydration state of juvenile hormone esterase inhibitors.
    Wheelock CE; Nakagawa Y; Akamatsu M; Hammock BD
    Bioorg Med Chem; 2003 Nov; 11(23):5101-16. PubMed ID: 14604674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of inhibitors of specific carboxylesterases: development of carboxylesterase inhibitors for translational application.
    Yoon KJ; Hyatt JL; Morton CL; Lee RE; Potter PM; Danks MK
    Mol Cancer Ther; 2004 Aug; 3(8):903-9. PubMed ID: 15299073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases.
    Wadkins RM; Hyatt JL; Wei X; Yoon KJ; Wierdl M; Edwards CC; Morton CL; Obenauer JC; Damodaran K; Beroza P; Danks MK; Potter PM
    J Med Chem; 2005 Apr; 48(8):2906-15. PubMed ID: 15828829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
    Hyatt JL; Moak T; Hatfield MJ; Tsurkan L; Edwards CC; Wierdl M; Danks MK; Wadkins RM; Potter PM
    J Med Chem; 2007 Apr; 50(8):1876-85. PubMed ID: 17378546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors.
    Tsurkan LG; Hatfield MJ; Edwards CC; Hyatt JL; Potter PM
    Chem Biol Interact; 2013 Mar; 203(1):226-30. PubMed ID: 23123248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicity.
    Hyatt JL; Tsurkan L; Wierdl M; Edwards CC; Danks MK; Potter PM
    Mol Cancer Ther; 2006 Sep; 5(9):2281-8. PubMed ID: 16985062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
    Hyatt JL; Wadkins RM; Tsurkan L; Hicks LD; Hatfield MJ; Edwards CC; Ross CR; Cantalupo SA; Crundwell G; Danks MK; Guy RK; Potter PM
    J Med Chem; 2007 Nov; 50(23):5727-34. PubMed ID: 17941623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicity.
    Hicks LD; Hyatt JL; Stoddard S; Tsurkan L; Edwards CC; Wadkins RM; Potter PM
    J Med Chem; 2009 Jun; 52(12):3742-52. PubMed ID: 19534556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity.
    Wadkins RM; Hyatt JL; Yoon KJ; Morton CL; Lee RE; Damodaran K; Beroza P; Danks MK; Potter PM
    Mol Pharmacol; 2004 Jun; 65(6):1336-43. PubMed ID: 15155827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity.
    Wong CC; Cheng KW; Xie G; Zhou D; Zhu CH; Constantinides PP; Rigas B
    J Pharmacol Exp Ther; 2012 Feb; 340(2):422-32. PubMed ID: 22085648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxylesterase Inhibitors: An Update.
    Zou LW; Jin Q; Wang DD; Qian QK; Hao DC; Ge GB; Yang L
    Curr Med Chem; 2018; 25(14):1627-1649. PubMed ID: 29210644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones.
    Parkinson EI; Jason Hatfield M; Tsurkan L; Hyatt JL; Edwards CC; Hicks LD; Yan B; Potter PM
    Bioorg Med Chem; 2011 Aug; 19(15):4635-43. PubMed ID: 21733699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil.
    Fleming CD; Bencharit S; Edwards CC; Hyatt JL; Tsurkan L; Bai F; Fraga C; Morton CL; Howard-Williams EL; Potter PM; Redinbo MR
    J Mol Biol; 2005 Sep; 352(1):165-77. PubMed ID: 16081098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation Capacity of Carboxylesterase in Skin and Keratinocytes for the Penta-Ethyl Ester Prodrug of DTPA.
    Fu J; Sadgrove M; Marson L; Jay M
    Drug Metab Dispos; 2016 Aug; 44(8):1313-8. PubMed ID: 27130352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide down-regulates carbolesterases 1 and 2 and reduces hydrolysis activity in vitro and in vivo via p38MAPK-NF-κB pathway.
    Mao Z; Li Y; Peng Y; Luan X; Gui H; Feng X; Hu G; Shen J; Yan B; Yang J
    Toxicol Lett; 2011 Mar; 201(3):213-20. PubMed ID: 21237253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.